
Indivi Raises CHF15 Million to Advance Biomarker Discovery for Alzheimer’s and Neuroscience Drug Development
Indivi Secures CHF 15 Million to Advance Biomarker Discovery in Alzheimer’s and Neuroscience Drug Development Indivi, an independent TechBio company pioneering precision medicine solutions for neuroscience, today announced the successful closing of a CHF 15 million investment round led by…












